Trends in breast cancer in the elderly in Denmark, 1980-2012

Acta Oncologica
Jeanette D JensenAcademy of Geriatric Cancer Research (AgeCare)

Abstract

Breast cancer is the most frequent malignancy among women worldwide and the second most common cause of cancer-related death in developed countries. The aim of the present analysis is to describe trends in incidence, mortality, prevalence, and relative survival in Denmark from 1980 to 2012 focusing on age, comparing persons aged 70 years or more with those aged less than 70 years. Cancer of the breast was defined as ICD-10 code C50. Data derived from the NORDCAN database with comparable data on cancer incidence, mortality, prevalence and relative survival in the Nordic countries, where the Danish data were delivered from the Danish Cancer Registry and the Danish Cause of Death Registry with follow-up for death or emigration until the end of 2013. The proportion of patients diagnosed with breast cancer over the age of 70 years increased with time to 29% of women and 44% of men in 2012. Incidence rates increased with time and peaked around 2010 in all age groups except for those aged 90 years or more. Mortality rates were clearly separated by age with increasing mortality rates by increasing age group for both women and men. Relative survival increased over time in all age groups, but patients aged 70 years or more had a poorer r...Continue Reading

References

Jan 15, 1989·International Journal of Cancer. Journal International Du Cancer·M EwertzH O Adami
Dec 30, 1999·The New England Journal of Medicine·L F HutchinsK S Albain
Mar 17, 2001·JAMA : the Journal of the American Medical Association·R YancikJ W Yates
Aug 13, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine BouchardyGeorges Vlastos
Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shelley M EngerRebecca A Silliman
Dec 1, 1948·The British Journal of Radiology·J CLEMMESEN
May 4, 2011·Critical Reviews in Oncology/hematology·Lotte Holm LandMarianne Ewertz
Oct 18, 2011·Breast Cancer Research and Treatment·Lotte Holm LandMarianne Ewertz
May 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeanne S MandelblattHarvey J Cohen
Feb 6, 2014·Acta Oncologica·Peer ChristiansenElsebeth Lynge
Feb 21, 2014·Journal of the National Cancer Institute·Louise A BrintonDavid B Thomas
May 9, 2014·Cancer Causes & Control : CCC·Louise A BrintonCher M Dallal
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William P TewStuart M Lichtman
Aug 12, 2014·Geriatrics & Gerontology International·Pegdwende Olivia DiallaTienhan Sandrine Dabakuyo-Yonli
Jan 20, 2016·Acta Oncologica·Marianne EwertzUNKNOWN Academy of Geriatric Cancer Research (AgeCare)

❮ Previous
Next ❯

Citations

May 16, 2017·Mechanisms of Ageing and Development·Shantell C NolenDaniela A Bota
Aug 15, 2017·Breast Cancer Research and Treatment·M LodiC Mathelin
Aug 11, 2017·International Journal of Cancer. Journal International Du Cancer·R KvåleB Møller
Sep 20, 2019·Breast Cancer Research and Treatment·Kiki M H VangangeltWilma E Mesker
Aug 23, 2019·Nutrition and Cancer·Natalia Mudarra GarcíaRaúl Pérez Muñoz
May 5, 2020·Acta Oncologica·Marianne VogsenUNKNOWN Academy for Geriatric Cancer Research (AgeCare)
Jul 11, 2018·Annals of Surgical Oncology·Sarah L BlairLorraine Tafra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Oncologica
Katrine R SchønnemannAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Charlotte KristiansenAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Stine Brændegaard WintherAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Jon Kroll BjerregaardAcademy of Geriatric Cancer Research (AgeCare)
© 2022 Meta ULC. All rights reserved